Volume 11, Number 10—October 2005
Research
Community-associated Methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003
Jessica M. Buck*
, Kathryn Como-Sabetti*, Kathleen H. Harriman*, Richard N. Danila*, David J. Boxrud*, Anita Glennen*, and Ruth Lynfield*
, Kathryn Como-Sabetti*, Kathleen H. Harriman*, Richard N. Danila*, David J. Boxrud*, Anita Glennen*, and Ruth Lynfield*
Table 4
Distribution of HA-MRSA PFTs among invasive disease and SSTI community-associated MRSA isolates*
| HA-MRSA PFTs | Invasive disease isolates (n = 25), no. (%) | SSTI isolates (n = 99), no. (%) |
|---|---|---|
| USA100 | 17 (28) | 43 (8) |
| USA200 | 3 (5) | 4 (0.8) |
| USA500 | 5 (8) | 40 (7.6) |
| USA600 | 0 | 1 (0.2) |
| USA700 | 0 | 1 (0.2) |
| USA800 | 0 | 10 (2) |
| Total† | 25 (42) | 99 (19) |
*HA, healthcare-associated; MRSA, methicillin-resistant Staphylococcus aureus; PFTs, pulsed-field types; SSTI, skin and soft tissue infection.
†Odds ratio 3.63, 95% confidence interval 2.03–6.50, p<0.001.
Page created: February 22, 2012
Page updated: February 22, 2012
Page reviewed: February 22, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.